Extracorporeal Membrane Oxygenation Evaluated by Transcranial Doppler.
ECMO-DTC
2 other identifiers
interventional
30
1 country
1
Brief Summary
To determine how venoarterial extracorporeal membrane oxygenation (ECMO) affects cerebral blood flow velocity (CBFV) measured by transcranial doppler (TCD), to determine whether specific changes in cerebral blood flow velocity may be associated with neurologic injury and to determine modifications of CBFV after withdrawal of ECMO.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2018
CompletedFirst Posted
Study publicly available on registry
March 7, 2018
CompletedStudy Start
First participant enrolled
April 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedApril 18, 2018
April 1, 2018
2.4 years
February 27, 2018
April 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cerebral blood flow velocities evolution
Cerebral blood flow velocities evolution over the time
24 hours
The correlation of Cerebral blood flow velocities with the variation of the cardiac output and ECMO flow.
The correlation with the variation of the cardiac output and ECMO flow.
24 hours
Secondary Outcomes (3)
Relation between acute neurologic injury and variation of CBFV
24 hours
Modification of the CBFV detected by TCD after the withdrawal of the ECMO.
24 hours
Relation between the CBFV, the NIRS, the cardiac flow and the ECMO flow.
24 hours
Study Arms (1)
Patient treated with ECMO
EXPERIMENTALPatient treated with ECMO will have Examination : a TCD and Trans-Thoracic Echocardiography (TTE)
Interventions
Examination that involves the completion of a TCD and an TTE (Trans-Thoracic Echocardiography) : * To reports clinical parameters at the time of the examination : ECG data: sinus rhythm, atrial or ventricular arrhythmia, state of consciousness, heart rate, O2 saturation * To review of pharmacological parameters at the time of the examination : presence of sedation; presence, type and dose of catecholamines. * To collect biological data from the day of the examination : Partial Pressure of O2, PaCO2 (partial pressure) and hematocrit * To collect possible additional examinations : brain scan, EEG. These are non-invasive exams that do not require patient displacement. Only the samples taken by the medical team as part of the treatment will be analyzed.
Eligibility Criteria
You may qualify if:
- adult patient who receiving ECMO therapy
You may not qualify if:
- cervico-encephalic vasculopathy
- lacked an acoustic window allowing for adequate TCD examination
- stroke in medical past.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Toulouse
Toulouse, 31059, France
Study Officials
- PRINCIPAL INVESTIGATOR
Fanny BOUNES, MD
University Hospital, Toulouse
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2018
First Posted
March 7, 2018
Study Start
April 5, 2018
Primary Completion
September 1, 2020
Study Completion
September 1, 2020
Last Updated
April 18, 2018
Record last verified: 2018-04